Yes, Valtoco is a controlled substance. It contains diazepam, which is classified as a Schedule IV controlled substance under the federal Controlled Substances Act. This means it has a recognized medical use but carries some potential for misuse and dependence, placing it in the same legal category as other benzodiazepines like lorazepam and clonazepam.
What Schedule IV Means for Your Prescription
The DEA’s scheduling system runs from Schedule I (highest restriction) to Schedule V (lowest). Schedule IV sits near the lower end, reflecting a moderate but real risk of dependence. For you as a patient or caregiver, this classification creates specific rules around how Valtoco is prescribed and dispensed.
Federal law limits Schedule IV prescriptions in two ways. First, the prescription expires six months after the date it was written. Second, you can only refill it up to five times within that six-month window. After that, your doctor needs to write a new prescription. Partial fills are allowed, but no dispensing can happen once those six months have passed. Some states impose additional restrictions on top of the federal rules, so your pharmacy may have slightly different policies.
Because Valtoco is a controlled substance, you won’t be able to get it called in or transferred between pharmacies as easily as a non-controlled medication. Your prescriber may also need to check your state’s prescription drug monitoring program before writing or renewing the prescription.
What Valtoco Is and How It Works
Valtoco is a nasal spray form of diazepam, FDA-approved for managing seizure clusters (also called acute repetitive seizures) in patients six years of age and older. It’s not a daily medication. Instead, it’s designed as a rescue treatment, something a caregiver administers when a person is actively having a seizure episode.
Diazepam works by boosting the activity of a calming brain chemical called GABA. When it binds to specific receptor sites in the brain, it enhances GABA’s natural inhibitory effect, which helps stop the excessive electrical activity that causes seizures. The nasal spray format makes it practical for emergency situations where swallowing a pill isn’t possible.
After a dose is sprayed into the nose, diazepam absorbs almost completely, with bioavailability reaching about 97%. It typically reaches peak blood levels around 1.5 hours after administration, though it begins working before that peak.
Available Doses and How It’s Given
Valtoco comes in three strengths: 5 mg, 7.5 mg, and 10 mg. The prescribed dose depends on both the patient’s age and weight. Children aged 6 to 11 are dosed at a higher ratio per kilogram of body weight than patients 12 and older. Actual doses range from 5 mg for smaller children to 20 mg for larger adults.
Lower doses (5 mg or 10 mg) require a single spray device in one nostril. Higher doses (15 mg or 20 mg) use two devices, one sprayed into each nostril. A caregiver handles the administration: they gently insert the nozzle tip into the nostril, press the plunger firmly, then remove the device. The person receiving the medication can be lying on their side or back.
After giving the spray, caregivers should move the person onto their side, loosen any tight clothing, and watch them closely in a safe area where they can rest.
Risks Tied to Its Controlled Status
The Schedule IV classification exists because all benzodiazepines, including diazepam, can cause physical dependence with repeated use. Even at prescribed doses, the body can become accustomed to the drug over time. This is less of a concern with Valtoco than with daily benzodiazepines, since it’s intended only for occasional rescue use during seizure emergencies. Still, the risk is present and is why the prescription carries controlled substance restrictions.
Combining Valtoco with opioids, alcohol, or other sedating substances increases the risk of severe drowsiness, dangerously slowed breathing, and loss of consciousness. This interaction is serious enough that it carries a prominent warning on the label. If the person taking Valtoco uses any of these substances, their prescriber needs to know.
Storing and Disposing of a Controlled Nasal Spray
Valtoco should be stored at room temperature, between 68°F and 77°F, and kept away from light. Don’t freeze it. Because it’s a controlled substance, unused devices shouldn’t just sit in a medicine cabinet indefinitely. Federal guidelines recommend properly disposing of any unused controlled medication rather than keeping it around where it could be accessed by others. After using a device, throw away both the spray and its blister pack. For unused or expired devices, ask your pharmacist about drug take-back programs or FDA-recommended disposal methods for controlled substances.